Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...

Alcon and RxSight partner to develop light-adjustable presbyopia-correcting IOLs, including $60M upfront and milestone payments.

Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the ...

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of Directors, effective today, expanding the Board from nine ...

Alcon’s ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming ...

Novartis has completed the spinoff of Alcon, an eye-care company it acquired nearly a decade ago for $12.9 billion. The Basel, Switzerland-based company first announced the planned separation in June ...

Price change The price of ALC shares has decreased $1.56 since the market last closed. This is a 2.24% drop. Opened at $68.64. The stock opened $1.02 lower than its previous close.

Alcon Inc. Annual stock financials by MarketWatch. View the latest ALC financial statements, income statements and financial ratios.

Add Yahoo as a preferred source to see more of our stories on Google. Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its ...